EPA Deregulation Means More Air Pollution and More Cancer Deaths

May 16th 2025, 9:00pm

By Dr. Joan H. Schiller

Understanding Unique Treatment Options Across Bladder Cancer Care

May 16th 2025, 8:00pm

By Dr. Daniel Petrylak

Dr. Daniel P. Petrylak discusses the different types of bladder cancer and how treatment options may vary based on disease stage and type.

Brain Cancer Awareness Month Highlights Advances in Radiation Therapy

May 16th 2025, 7:01pm

By Ryan Scott

Dr. Ranjit S. Bindra discusses recent advancements for the treatment of patients with primary brain tumors during Brain Cancer Awareness Month.

Tips for Combating Lymphedema After Breast Cancer

May 16th 2025, 5:00pm

By Felicia Mitchell

With proper precautions, international travel and safeguarding an arm with lymphedema are possible. Always prioritize your health and seek medical advice.

Samuraciclib Therapy Combo Shows Responses in HR+ Advanced Breast Cancer

May 16th 2025, 4:00pm

By Ryan Scott

Recent phase 2 data support combination treatment with samuraciclib for those with HR+ advanced breast cancer following prior CDK4/6 inhibitor therapy.

Leronlimab Linked to Increased PD-L1 in Triple-Negative Breast Cancer

May 16th 2025, 2:41pm

By Spencer Feldman

Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to immune checkpoint inhibitors.

Preparing For Survivorship After Lymphoma Treatment in AYA PatientsPreparing For Survivorship After Lymphoma Treatment in AYA Patients

May 16th 2025, 1:00pm

By Dr. Kara Kelly

Dr. Kara Kelly discusses specific long-term health considerations that AYA survivors of lymphoma should be aware of to best prepare for survivorship.

Bladder Cancer Awareness Month Highlights the Importance of Early Detection

May 15th 2025, 9:00pm

By Ryan Scott

Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the disease.

Robotic Kidney Cancer Surgery May Aid Recovery, Spare Kidney Function

May 15th 2025, 8:00pm

By Dr. Armine Smith

Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith.

FDA Approves Zynyz Treatment Regimen for Advanced Anal Cancer

May 15th 2025, 7:27pm

By Spencer Feldman

The FDA has approved Zynyz as a first-line treatment in combination with chemo and as a single-agent following progression in advanced anal cancer.

Finding Comfort in Teddy Bears Throughout My Experience With CLL

May 15th 2025, 5:00pm

By Chester Freeman

As a patient with CLL, I’ve found comfort in teddy bears — first as a chaplain offering solace, now as a patient embracing their quiet presence myself.

Ventana MET RxDx Assay Receives FDA Approval as Companion Diagnostic in NSCLC

May 15th 2025, 4:00pm

By Ryan Scott

The FDA approved the Ventana MET RxDx assay, making it the first companion diagnostic to aid in determining MET protein expression in non-squamous NSCLC.

Efti Plus Keytruda With Chemo Shows High Response in NSCLC Subset

May 15th 2025, 3:00pm

By Spencer Feldman

Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, outperforming historical data.

Lumakras Plus Vectibix Shows Potential in KRAS G12C Colorectal Cancer

May 15th 2025, 1:00pm

By Spencer Feldman

Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though not statistically significant.

Patient Education, Shared Decision-Making, and Optimizing Care for ESR1-Mutated Breast Cancer

May 15th 2025, 12:05pm

By Virginia Kaklamani, MD, DSc

Panelists discuss how a multidisciplinary team approach to patient education and medication management is crucial for ensuring adherence and optimal outcomes with oral medications like elacestrant